Skip to main content
. 2018 Sep 11;9:2077. doi: 10.3389/fimmu.2018.02077

Table 1.

The characteristics of studies included in the meta-analysis.

References Country Method Outcome Case number (High/Low) Cut-off Follow up time
Dai et al. (17) China Tissue Microarray, Immunohistochemistry OS DFS 90(28/62) Staining scores <2 Median time 60.8 month
Sideras et al. (18) Netherlands Tissue Microarray, Immunohistochemistry, PCR RFS EMC86(70/16) 2 log likelihood >100 months
AMC 60(51/9)
Semaan et al. (31) Germany Tissue microarray, Immunohistochemistry OS 176(88/88) Median 60 months
Xie et al. (32) China Immunohistochemistry OS DFS 167(24/143) Membranous staining = 5% of tumor cells 150 months
Chen et al. (16) China Immunohistochemistry OS RFS 231(58/173) Membranous staining percentage = 5% >5 years
Jung et al. (30) Korea Immunohistochemistry OS DFS 85(23/62) Staining scores = 3 125 months
Umemoto et al. (33) Japan Immunohistochemistry OS RFS 80(37/43) Staining score = 1 median time 2,427 days
Zeng et al. (34) China Immunohistochemistry OS DFS 156(88/68) Staining score = 1 40 months
Gao et al. (6) China Tissue microarray, Immunohistochemistry OS RFS DFS 240(60/180) The 75th percentile 120 months
Gabrielson et al. (35) America Immunohistochemistry, semi-quantitative analysis OS RFS 58(19/39) NA meantime 39.7 months
Kan et al. (36) China Immunohistochemical Staining OS 128(105/23) 1 point median time 10 months
Wu et al. (4) China Immunohistochemistry OS 71(35/36) The median value of B7-H1+cell density in tumor tissues on IHC 80 months
Finkelmeier et al. (37) Germany ELISA OS 215(64/151) 0.8 ng/ml 298 ± 304 days with a range of 1–1464 days